Dipenkumar Modi, M.D.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Intellectual Property Other
    Ineligible company: 
    Beigene
    Topic: 
    Speakers' Bureau
    Date added: 
    03/27/2023
    Relationship end date: 
    12/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Intellectual Property Other
    Ineligible company: 
    AstraZeneca
    Topic: 
    Expert Testimony
    Date added: 
    03/27/2023
    Relationship end date: 
    12/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Intellectual Property Other
    Ineligible company: 
    Seagen
    Topic: 
    Advisory board
    Date added: 
    03/27/2023
    Relationship end date: 
    12/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Intellectual Property Other
    Ineligible company: 
    Genentech
    Topic: 
    Research support
    Date added: 
    03/27/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Intellectual Property Other
    Ineligible company: 
    ADC Therapeutics
    Topic: 
    Reserach support
    Date added: 
    03/27/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Intellectual Property Other
    Ineligible company: 
    Karyopharm
    Topic: 
    Research support
    Date added: 
    03/27/2023
  • Attribution: 
    Spouse or Partner
    Type of financial relationship: 
    Intellectual Property Other
    Ineligible company: 
    AstraZeneca
    Date added: 
    03/27/2023
  • Attribution: 
    Spouse or Partner
    Type of financial relationship: 
    Intellectual Property Other
    Ineligible company: 
    Genentech
    Date added: 
    03/27/2023
Return to Multiple Myeloma & Lymphoma Summit